Every campaign starts with one donation.

The latest recall adds to growing safety concerns surrounding compounded glutathione, promoted as an injectable treatment for skin lightening and other unproven effects ...

Andrew Kolodny, M.D., has treated enough people with opioid addiction to recognize withdrawal when he sees it: sweating, vomiting, agonizing pain. But increasingly, he says, patients are presenting ...

Welcome to the FDA Recalls and Warnings Update, a series dedicated to keeping you informed about the latest medication recalls, manufacturing violations, and quality concerns affecting your ...

A bipartisan bill promised greater transparency into where prescription drugs are manufactured. Then a key provision was ...

Doctors say the growing popularity of supplement stacking has exposed more Americans to botanicals like ashwagandha that can damage the liver.

I went to Washington, D.C., to push for greater accountability and stronger safety protections for patients who rely on brand-name and generic drugs ...

Drug holidays are often discussed on social media, particularly for ADHD medications and GLP-1s. But while planned breaks make sense for certain drugs, for others they’re unproven, and potentially ...

Welcome to the FDA Recalls and Warnings Update, a series dedicated to keeping you informed about the latest medication recalls, manufacturing violations, and quality concerns affecting your ...

Millions of Americans take glucosamine for joint pain despite limited evidence that it works. Now, a new study suggests it could accelerate cognitive decline in some people with dementia ...

Simtriyo is being promoted as a new kind of ADHD drug that may help with emotional dysregulation. But the strongest evidence so far is for core ADHD symptoms, and questions remain about how it ...

Scientists have identified genetic variants that make certain medications far more toxic for some people. The challenge is getting that information into the exam room ...